Projects per year
Personal profile
Education/Academic qualification
PhD, Kimyasal karsinojenezle oluşturulmuş meme tümör hücrelerinin CD40 ligand ile genetik modifikasyonu ve allojenik aşı preparatı olarak kullanılabilirliğinin değerlendirilmesi, Hacettepe University
2003 → 2007
Master, CD40 ligand (CD154) genin ökaryotik ekspresyon vektörüne klonlanması, Hacettepe University
2001 → 2003
Bachelor, İSTANBUL ÜNİVERSİTESİ
1997 → 2001
External positions
Yönetim Kurulu Üyeliği, Hacettepe University
2017 → …
Erasmus Koordinatörü , Hacettepe University
2012 → …
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Güneş Esendağlı is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Mide Ve Pankreas Kanserinde Dalak Ve Periferik Kan Miyeloid-Kökenli Baskılayıcı Hücrelerin Karşılaştırmalı Analizi
Esendağlı, G. (PI)
1/09/17 → …
Project: Research › TUBITAK
-
Mide Ve Pankreas Kanserinde Dalak Ve Periferik Kan Miyeloid-Kökenli Baskılayıcı Hücrelerin Karşılaştırmalı Analizi
Esendağlı, G. (Unknown)
1/09/17 → …
Project: Research › TUBITAK
-
Splenektomize farelerde aspirinin tümör immünoloji üzerine etkileri
Esendağlı, G. (CoI)
1/04/16 → …
Project: Research › SRP
-
Prostat Kanseri Tedavisi İçin Yeni Nesil Sentetik Ajanların Geliştirilmesi
Esendağlı, G. (CoI)
1/04/16 → …
Project: Research › TUBITAK
-
Splenektomize farelerde aspirinin tümör immünoloji üzerine etkileri
Esendağlı, G. (Unknown)
1/04/16 → …
Project: Research › SRP
-
Alterations in PD-L1+ Myeloid Cells and Immune Infiltration Are Associated with Atezolizumab and Paclitaxel Therapy Success in a Triple-Negative Breast Cancer Model
Yilmaz, K. B., Tavukcuoglu, E., Yanik, H., Seçken, P., Celik, E., Guler, S., Hidiroglu, M. M., Bahcecioglu, I. B., Erturk, I., Gulcelik, M. A., Karakoc, D. & Esendagli, G., Mar 2026, In: Medicina (Lithuania). 62, 3, 600.Research output: Contribution to journal › Article › peer-review
Open Access -
CD44-targeted cyclodextrin-hyaluronic acid nanoparticles carrying gemcitabine and paclitaxel to pancreatic cancer
Varan, G., Demirtürk, N., Gökşen, S., Benito, J. M., Malanga, M., Öztürk, S. C., Esendağlı, G. & Bilensoy, E., 1 Jun 2026, In: European Journal of Pharmaceutical Sciences. 221, 107527.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Clinical significance of CD27+CD28+ effector memory T cells as potential prognostic biomarkers in ovarian cancer
Uluturk, S., Aras, I. A., Altahhan, V., Sakar, V., Karadurmus, B., Hidiroglu, M. M., Guler, S., Bahcecioglu, I. B., Ozdemir, O., Erturk, I., Gulcelik, M. A., Yilmaz, K. B. & Esendagli, G., Dec 2026, In: Journal of Ovarian Research. 19, 1, 178.Research output: Contribution to journal › Article › peer-review
Open Access -
Detection of inflammation and glial cell-related biomarkers in adults with spinal muscular atrophy receiving nusinersen therapy
Arslan, D., Ergul-Ulger, Z., Goksen, S., Inan, B., Esendagli, G., Erdem-Ozdamar, S., Tan, E. & Bekircan-Kurt, C. E., Jan 2026, In: Neurological Sciences. 47, 1, 40.Research output: Contribution to journal › Article › peer-review
-
Development and in vitro/in vivo evaluation of polymeric dissolving microneedle formulation for psoriasis treatment
Kaplan, M., Arslan, F. B., Öztürk, S. C., Ulutürk, S., Meriçöz, Ç. A., Esendağlı, G., Çalış, S. & Öztürk, K., 1 Mar 2026, In: European Journal of Pharmaceutical Sciences. 218, p. 107429 107429.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)